|
Volumn 2, Issue 3, 1996, Pages 55-80
|
A comparison of piperacillin/tazobactam versus imipenem: Formulary considerations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA LACTAMASE INHIBITOR;
IMIPENEM;
PIPERACILLIN;
TAZOBACTAM;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
CELL WALL;
DATA ANALYSIS;
DECISION MAKING;
DISEASE ASSOCIATION;
DRUG COST;
DRUG EXCRETION;
DRUG FORMULATION;
DRUG MARKETING;
DRUG URINE LEVEL;
ENZYME ACTIVATION;
ENZYME INHIBITION;
GRAM NEGATIVE BACTERIUM;
HEADACHE;
HUMAN;
INSOMNIA;
SEIZURE;
SEPSIS;
|
EID: 0030391610
PISSN: 10687777
EISSN: None
Source Type: Journal
DOI: 10.1300/J100v02n03_05 Document Type: Article |
Times cited : (3)
|
References (81)
|